Fir Tree Capital Management’s Starling Oncology, Inc. Warrant STLNW Stock Holding History

Fir Tree Capital Management’s Portfolio STLNW Stock Details STLNW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-57,800	Closed	-$113K	–	447
2020 Q4	$113K	Sell	57,800 -4,700	-8%	-$8.11K	0.01%	162
2020 Q3	$106K	Hold	62,500	–	–	0.01%	112
2020 Q2	$93K	Buy	+62,500	New	+$89.7K	0.01%	70

Other funds holding STLNW

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

RCM

Radcliffe Capital Management Bala Cynwyd, Pennsylvania $1.33B AUM 1.18% 1-Year Est. Return

UOC

UBS O'Connor Chicago, Illinois $3.38B AUM 63.08% 1-Year Est. Return

SRCM

Sage Rock Capital Management New York $22.3M AUM 4.09% 1-Year Est. Return

DKCM

Davidson Kempner Capital Management New York $7.33B AUM 56.47% 1-Year Est. Return

Magnetar Financial Evanston, Illinois $9.84B AUM 190.63% 1-Year Est. Return

ECM

Element Capital Management New York $1.05B AUM 5.05% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

GCL

Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return

Man Group London, United Kingdom $55.1B AUM 24.23% 1-Year Est. Return

Fir Tree Capital Management's STLNW Position: Q1 2021 in Review

Fir Tree Capital Management sold out of Starling Oncology, Inc. Warrant (STLNW) in Q1 2021, closing a stake of 57,800 shares — an estimated $113K sold.

Fir Tree Capital Management first reported a position in STLNW in Q2 2020 and held it in 3 quarters. The position peaked at $113K in Q4 2020. 29 funds tracked by Wall St. Rank hold STLNW as of Q1 2021.

Fir Tree Capital Management reported no remaining Starling Oncology, Inc. Warrant position as of Q1 2021 after selling out during the quarter.
Fir Tree Capital Management sold 57,800 Starling Oncology, Inc. Warrant shares in Q1 2021, an estimated $113K.
Fir Tree Capital Management first reported a position in Starling Oncology, Inc. Warrant in Q2 2020 and held it in 3 quarters.
Fir Tree Capital Management's Starling Oncology, Inc. Warrant position peaked at $113K in Q4 2020.
29 funds tracked by Wall St. Rank held Starling Oncology, Inc. Warrant as of Q1 2021.

Based on Fir Tree Capital Management's 13F filing for Q1 2021, filed 17 May 2021.